Kowal Investment Group’s Amgen AMGN Stock Holding History

Kowal Investment Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-255	Closed	-$54K	–	148
2021 Q3	$54K	Buy	+255	New	+$58.7K	0.02%	232

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kowal Investment Group's AMGN Position: Q4 2021 in Review

Kowal Investment Group sold out of Amgen (AMGN) in Q4 2021, closing a stake of 255 shares — an estimated $54K sold.

Kowal Investment Group first reported a position in AMGN in Q3 2021 and held it in 1 quarter. The position peaked at $54K in Q3 2021. 2,294 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

Kowal Investment Group reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
Kowal Investment Group sold 255 Amgen shares in Q4 2021, an estimated $54K.
Kowal Investment Group first reported a position in Amgen in Q3 2021 and held it in 1 quarter.
Kowal Investment Group's Amgen position peaked at $54K in Q3 2021.
2,294 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.